An early (3-6 weeks) active surveillance study to assess the safety of pandemic influenza vaccine Focetria(®) in a province of Emilia-Romagna region, Italy - Part one

An observational, non-comparative, prospective, surveillance study of individuals vaccinated with the MF59-adjuvanted A/H1N1 influenza vaccine, Focetria(®), (Novartis Vaccines & Diagnostics, Siena, Italy), was performed in Italy during the 2009 A/H1N1 influenza pandemic.

Link al full text (se abilitati)
Vaccine. 2012 Jul 2. [Epub ahead of print]

[SINTESI]